WA
www.atheonbio.com
InactiveThe startup develops anti-tumor therapeutics that target the tumor microenvironment (TME) to enhance the efficacy of existing antibody treatments for solid tumors. By addressing the limitations of current anticancer drugs, the company aims to improve treatment outcomes for cancer patients.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$750KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops anti-tumor therapeutics that target the tumor microenvironment (TME) to enhance the efficacy of existing antibody treatments for solid tumors. By addressing the limitations of current anticancer drugs, the company aims to improve treatment outcomes for cancer patients.